Genetic Analysis AS (XSAT:GEAN)

Genetic Analysis AS Statistics

Total Valuation

XSAT:GEAN has a market cap or net worth of SEK 57.75 million. The enterprise value is 41.22 million.

Market Cap	57.75M
Enterprise Value	41.22M

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

XSAT:GEAN has 69.09 million shares outstanding. The number of shares has increased by 67.33% in one year.

Current Share Class	69.09M
Shares Outstanding	69.09M
Shares Change (YoY)	+67.33%
Shares Change (QoQ)	+39.90%
Owned by Insiders (%)	8.59%
Owned by Institutions (%)	11.19%
Float	32.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.78
PB Ratio	1.88
P/TBV Ratio	3.78
P/FCF Ratio	9.07
P/OCF Ratio	8.50
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.52
EV / Sales	1.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	6.48

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.23.

Current Ratio	2.30
Quick Ratio	2.27
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	1.10
Interest Coverage	-101.25

Financial Efficiency

Return on equity (ROE) is -32.85% and return on invested capital (ROIC) is -16.94%.

Return on Equity (ROE)	-32.85%
Return on Assets (ROA)	-12.35%
Return on Invested Capital (ROIC)	-16.94%
Return on Capital Employed (ROCE)	-23.94%
Revenue Per Employee	1.30M
Profits Per Employee	-569,644
Employee Count	16
Asset Turnover	0.45
Inventory Turnover	4.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.65% in the last 52 weeks. The beta is 2.40, so XSAT:GEAN's price volatility has been higher than the market average.

Beta (5Y)	2.40
52-Week Price Change	+24.65%
50-Day Moving Average	0.85
200-Day Moving Average	0.81
Relative Strength Index (RSI)	53.74
Average Volume (20 Days)	25,107

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:GEAN had revenue of SEK 20.80 million and -9.11 million in losses. Loss per share was -0.18.

Revenue	20.80M
Gross Profit	17.33M
Operating Income	-9.04M
Pretax Income	-9.11M
Net Income	-9.11M
EBITDA	-8.73M
EBIT	-9.04M
Loss Per Share	-0.18

Balance Sheet

The company has 23.46 million in cash and 7.01 million in debt, giving a net cash position of 16.45 million or 0.24 per share.

Cash & Cash Equivalents	23.46M
Total Debt	7.01M
Net Cash	16.45M
Net Cash Per Share	0.24
Equity (Book Value)	30.76M
Book Value Per Share	0.45
Working Capital	18.10M

Cash Flow

In the last 12 months, operating cash flow was 6.79 million and capital expenditures -430,523, giving a free cash flow of 6.36 million.

Operating Cash Flow	6.79M
Capital Expenditures	-430,523
Free Cash Flow	6.36M
FCF Per Share	0.09

Margins

Gross margin is 83.32%, with operating and profit margins of -43.48% and -43.83%.

Gross Margin	83.32%
Operating Margin	-43.48%
Pretax Margin	-43.83%
Profit Margin	-43.83%
EBITDA Margin	-41.96%
EBIT Margin	-43.48%
FCF Margin	30.60%

Dividends & Yields

XSAT:GEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.33%
Shareholder Yield	n/a
Earnings Yield	-15.78%
FCF Yield	11.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:GEAN has an Altman Z-Score of 0.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.77
Piotroski F-Score	5